Hot Investor Mandate: Investment Arm of Global Asset Management Firm Invests Up to $20M in Medical Device and Digital Health Companies, Focusing on US and Europe

4 Feb

A healthcare investment arm of a multi-strategy asset management firm focuses on early-stage opportunities in the medical device and digital health sectors, having invested approximately $250M USD in healthcare and medtech. The firm typically engages in Series A rounds and beyond, with check sizes ranging from $5M to $20M USD, and follow-on investments are a possibility. While the firm primarily focuses on the US (especially the Bay Area) and Europe, it remains open to global opportunities. 
 
The firm primarily considers opportunities in medical devices and digital health. Traditional asset-driven therapeutics are out of scope. The firm is agnostic to subsectors and indications but prefers disease areas with large addressable markets and companies with a clear reimbursement strategy. Some areas of interest include cardiovascular, ophthalmology, and diabetes. The fund typically evaluates clinical-stage opportunities but is open to considering design-stage companies, provided they have strong validation. 
 
The firm does not have specific requirements for a company’s founding team. However, the firm prefers founders with experience or a successful track record. 
 
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com. 

Leave a comment